Comprehensive TCR repertoire analysis of CD4+ T-cell subsets in rheumatoid arthritis. 2020

Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College; The Ministry of Education Key Laboratory, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, 100730, China.

The pathogenesis of rheumatoid arthritis (RA), a systemic autoimmune disease characterized by autoreactive T-cell accumulation and pro-inflammatory cytokine overproduction, is unclear. Systematically addressing T-cell receptor (TCR) repertoires of different CD4+ T-cell subsets could help understand RA pathogenesis. Here, peripheral CD4+ T cells from treatment-naïve RA patients and healthy controls were sorted into seven subsets including naïve, effector, central memory, effector memory (EMT), Th1, Th17, and regulatory T cells. T-cell receptor β chain repertoires were then analyzed by next-generation sequencing. We identified T-cell clonal expansion in EMT and Th17 cells of RA patients, with highly similar TCR repertoires. Ex vivo experiments demonstrated the preferred differentiation from EMT to Th17 cells in RA. Notably, we showed that TCR diversity and abundance of differentiated T cells of Th17 were significantly correlated with RA disease activity. Based on these observations, we propose that abnormal differentiation from EMT to Th17 and expansion of Th17 play pivotal role in RA pathogenesis.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D016176 T-Lymphocyte Subsets A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells. T-Cell Subset,T-Cell Subsets,T-Lymphocyte Subset,Subset, T-Cell,Subset, T-Lymphocyte,Subsets, T-Cell,Subsets, T-Lymphocyte,T Cell Subset,T Cell Subsets,T Lymphocyte Subset,T Lymphocyte Subsets

Related Publications

Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
May 2018, Journal of autoimmunity,
Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
August 2013, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
September 1996, Molecular medicine (Cambridge, Mass.),
Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
January 1997, Clinical and experimental rheumatology,
Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
September 2009, Journal of immunology (Baltimore, Md. : 1950),
Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
January 1998, International reviews of immunology,
Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
January 2015, Frontiers in immunology,
Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
May 2001, Clinical immunology (Orlando, Fla.),
Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
December 2020, Immunology,
Xu Jiang, and Shiyu Wang, and Chen Zhou, and Jinghua Wu, and Yuhao Jiao, and Liya Lin, and Xin Lu, and Bo Yang, and Wei Zhang, and Xinyue Xiao, and Yueting Li, and Xunyao Wu, and Xie Wang, and Hua Chen, and Lidan Zhao, and Yunyun Fei, and Huaxia Yang, and Wen Zhang, and Fengchun Zhang, and Hui Chen, and Jianmin Zhang, and Bin Li, and Huanming Yang, and Jian Wang, and Xiao Liu, and Xuan Zhang
January 2012, Journal of biomedicine & biotechnology,
Copied contents to your clipboard!